Tech Company Financing Transactions

NanoString Technologies Funding Round

AllianceBernstein, BioMed Ventures and Clarus participated in a $15.3 million Series E funding round for NanoString Technologies. This venture round closed on 12/3/2012.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Nanotechnology

Mailing Address

530 Fairview Ave. N
Seattle, WA 98109
USA

Phone

(888) 358-6266

Website

www.nanostring.com

Email Address

[email protected]

Overview

NanoString Technologies (NASDAQ: NSTG) is developing a patent pending platform for single molecule identification and digital quantification. The NanoString system uniquely barcodes individual target molecules, scans them, and delivers a literal inventory of target molecules in the biological sample.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Brad Gray

        

Chief Financial Officer

Thomas Bailey

        

VP - Bus. Development

David Ghesquiere

        

VP - General Counsel

Kathy Surace-Smith

        

VP - R & D

Joseph Beechem

        

VP - Sales

Chad Brown

        

Browse more venture capital transactions:

Prev: 12/3/2012: 1stdibs venture capital transaction
Next: 12/3/2012: Marqeta venture capital transaction

Share this article

Where The Data Comes From

We report on all VC transactions involving tech companies. VC transactions on this site are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary